CELLECTIS S.A. |
Market Closed -
Other stock markets
|
After market 10:03:15 pm | |||
| 2.435 EUR | -0.61% |
|
2.443 | +0.33% |
| 29/04 | Cellectis S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 29/04 | Cellectis S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 665.5 | 1,037 | 338.4 | 90.57 | 198.3 | 175.8 | - | - |
| Enterprise Value (EV) 1 | 403.7 | 905.2 | 242.2 | 52.81 | 198.3 | 157.1 | 51.14 | 175.8 |
| P/E ratio | -7.24 x | -15.4 x | -3.22 x | -0.9 x | - | - | - | - |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 32.2 x | 15.1 x | 5.57 x | 3.7 x | 23.1 x | 6.44 x | 2.17 x | 1.83 x |
| EV / Revenue | 19.5 x | 13.2 x | 3.99 x | 2.16 x | 23.1 x | 5.75 x | 0.63 x | 1.83 x |
| EV / EBITDA | -3.87 x | -14.4 x | -2.17 x | -0.56 x | - | -2.8 x | - | - |
| EV / FCF | -5.5 x | -8.66 x | -2.15 x | -0.63 x | - | -3.67 x | -0.7 x | -24 x |
| FCF Yield | -18.2% | -11.6% | -46.4% | -159% | - | -27.3% | -142% | -4.16% |
| Price to Book | 2.36 x | 4.56 x | 1.69 x | - | - | - | - | - |
| Nbr of stocks (in thousands) | 42,446 | 42,499 | 45,478 | 45,579 | 71,751 | 71,751 | - | - |
| Reference price 2 | 15.68 | 24.40 | 7.440 | 1.987 | 2.764 | 2.450 | 2.450 | 2.450 |
| Announcement Date | 04/03/20 | 04/03/21 | 03/03/22 | 08/03/23 | 29/04/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 20.65 | 68.46 | 60.69 | 24.5 | 8.58 | 27.32 | 81.02 | 95.97 |
| EBITDA 1 | -104.3 | -62.79 | -111.4 | -93.88 | - | -56.01 | - | - |
| EBIT 1 | -111 | -70.94 | -118.2 | -104.9 | -90.81 | -75.44 | -54.63 | -15.07 |
| Operating Margin | -537.42% | -103.62% | -194.83% | -428.31% | -1,058.44% | -276.15% | -67.43% | -15.7% |
| Earnings before Tax (EBT) 1 | -103.5 | -80.94 | -113.2 | -107.9 | -100.9 | -76.33 | -64.95 | -11.95 |
| Net income 1 | -91.7 | -67.32 | -103.3 | -100.5 | -94.32 | -69.24 | -62.73 | -9.357 |
| Net margin | -444.07% | -98.32% | -170.26% | -410.1% | -1,099.3% | -253.48% | -77.43% | -9.75% |
| EPS | -2.165 | -1.586 | -2.308 | -2.205 | - | - | - | - |
| Free Cash Flow 1 | -73.36 | -104.6 | -112.5 | -83.85 | - | -42.86 | -72.76 | -7.313 |
| FCF margin | -355.25% | -152.75% | -185.31% | -342.31% | - | -156.89% | -89.81% | -7.62% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 04/03/20 | 04/03/21 | 03/03/22 | 08/03/23 | 29/04/24 | - | - | - |
1EUR in Million
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 9.376 | 12.36 | 3.68 | 2.703 | 1.968 | 16.44 | 3.234 | 1.828 | 1.531 | 1.857 | 3.102 | 3.102 | 6.995 | 7 |
| EBITDA 1 | - | - | - | - | - | - | - | - | - | - | -21.48 | -23.96 | -7.22 | - |
| EBIT 1 | -36.69 | -27.98 | -33.85 | -33.31 | -33.98 | -7.92 | -21.29 | -21.61 | -19.24 | -27.61 | -21.19 | -22.04 | -17.89 | -18.97 |
| Operating Margin | -391.32% | -226.32% | -919.81% | -1,232.44% | -1,726.29% | -48.19% | -658.36% | -1,182.36% | -1,257.36% | -1,486.33% | -683.21% | -710.65% | -255.75% | -271% |
| Earnings before Tax (EBT) 1 | -34.7 | -25.41 | -33.38 | -19.02 | -32.03 | -26.95 | -29.56 | -12.41 | -16.18 | -39 | -20.29 | -20.33 | -22.47 | -18.97 |
| Net income 1 | -32.4 | -22.62 | -30.64 | -18.52 | -29.17 | -25.38 | -27.33 | -9.725 | -16.28 | -39.01 | -16.34 | -16.34 | -19.14 | -19.14 |
| Net margin | -345.55% | -182.95% | -832.75% | -685.24% | -1,481.88% | -154.43% | -845.01% | -532.13% | -1,063.38% | -2,100.25% | -526.69% | -526.69% | -273.59% | -273.39% |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 04/11/21 | 03/03/22 | 12/05/22 | 04/08/22 | 03/11/22 | 08/03/23 | 04/05/23 | 03/08/23 | 06/11/23 | 29/04/24 | - | - | - | - |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 262 | 132 | 96.2 | 37.8 | - | 18.7 | 125 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -73.4 | -105 | -112 | -83.9 | - | -42.9 | -72.8 | -7.31 |
| ROE (net income / shareholders' equity) | -28.2% | -27.5% | -45.2% | -62.6% | - | -12.7% | 3.95% | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | 6.630 | 5.350 | 4.400 | - | - | - | - | - |
| Cash Flow per Share | -1.460 | -1.570 | - | - | - | - | - | - |
| Capex 1 | 11.5 | 37.9 | 17.9 | 2.27 | - | 0.85 | 0.89 | 0.9 |
| Capex / Sales | 55.91% | 55.42% | 29.42% | 9.26% | - | 3.13% | 1.09% | 0.94% |
| Announcement Date | 04/03/20 | 04/03/21 | 03/03/22 | 08/03/23 | 29/04/24 | - | - | - |
1EUR in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -11.90% | 188M | |
| +0.49% | 42.86B | |
| +12.34% | 42.74B | |
| +44.30% | 41.36B | |
| -6.20% | 27.68B | |
| +5.70% | 25.15B | |
| -23.49% | 18.63B | |
| +28.22% | 12.37B | |
| -3.64% | 11.92B | |
| +6.69% | 11.21B |
- Stock Market
- Equities
- ALCLS Stock
- Financials Cellectis S.A.
